IBB

Stocks Surge to Start November

Investors look ahead to the remainder of the Q3 earnings season, a number of Fed speakers on Wednesday and the all-important October jobs report on Friday. More 

Gilead Sciences, Inc. – GILD Stock Catches the Bears Off Guard Again

Biotechnology stocks as a group are not yet out of the woods, but single-name stocks like GILD stock look promising right now. More 

Trade of the Day: IBB Still a Stellar Long-Term Buy

iShares NASDAQ Biotechnology Index (ETF) is headed for $400-plus. More 

Stocks Wilt on Earnings and Oil Decay

The short rally in stocks was stopped on several below-average earnings reports coupled with a downturn in oil. Housing starts, however, saw a nice gain. More 

Why Now Is the Time to Pile Back Into Biotech Stocks (IBB, XBI)

For years, biotech stocks have outperformed the market. In light of their recent downturn, now's a fine time to buy biotech ETFs like IBB and XBI. More 

Bet on a Bounce with These Biotech ETFs

Biotech stocks may have taken a beating lately, but that may just make these biotech ETFs more of a bargain. More 

Stocks Hit Resistance as Meltup Continues

Although the markets have seemed to rebound, the Dow is still down 5.1% YTD, the S&P 500 is dealing with resistance and Q3 looks weak. More